Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib versus diclofenac SR plus omeprazole for gastrointestinal events in high gastrointestinal risk osteoarthritis or rheumatoid arthritis
2004-001234-17Phase 4Completed
- Sponsor
- Pfizer
- Start
- Sep 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in osteoarthritis (OA) and rheumatoid arthritis (RA) comparing Celebrex arm with Voltarol SR plus Losec arm (2 arms). Primary endpoint: Incidence of clinically significant upper and/or lower gastrointestinal events. Started Sep 2005; status: completed.
02
Drugs
celecoxibdiclofenacomeprazole
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-001234-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001234-17.